Magnesium Forms Compared: Glycinate, L-Threonate, Malate, Citrate & Oxide — Which Form for Which Goal?

Not all magnesium supplements are equal. Oxide barely absorbs. L-threonate crosses the blood-brain barrier. Glycinate calms the nervous system. Malate fuels mitochondrial energy. Here is the evidence-based breakdown of every major form.

Why Magnesium Matters: The Body's Master Mineral

Magnesium is the fourth most abundant mineral in the human body and the second most abundant intracellular cation after potassium. It participates in more biochemical reactions than virtually any other mineral — yet surveys consistently show that the majority of Western populations fall short of even the conservative RDA (310–420 mg/day for adults).

The functional consequences of this widespread subclinical deficiency are broad and often overlooked because serum magnesium (the standard lab test) reflects only about 1% of total body magnesium. Intracellular and bone stores can be depleted for years before serum levels fall out of range.

ATP Synthesis and Energy Metabolism

Every molecule of ATP (adenosine triphosphate) must be bound to a magnesium ion to be biologically active. The form the cell uses is not ATP⁴⁻ but Mg-ATP. Without adequate magnesium, cellular energy production stalls at every step — from glycolysis and the Krebs cycle to oxidative phosphorylation. This is why muscle fatigue, exercise intolerance, and chronic low energy are among the earliest reported symptoms of magnesium insufficiency.

Protein Synthesis and DNA Repair

Magnesium stabilises ribosomes and is required for the correct translation of mRNA into protein. It also directly binds DNA and RNA, stabilising their double-helix structures. Multiple DNA polymerases — the enzymes responsible for replicating and repairing the genome — are magnesium-dependent metalloenzymes. Magnesium deficiency therefore accelerates genomic instability and impairs the cellular repair machinery associated with healthy aging.

Neuromuscular Function and Voltage-Gated Channels

Magnesium is a natural calcium channel blocker. It occupies the NMDA (N-methyl-D-aspartate) receptor channel in a voltage-dependent manner, preventing excessive calcium influx during neuronal firing. This dual role — as a muscle relaxant and excitatory neurotransmitter brake — explains why magnesium deficiency produces muscle cramps, fasciculations, hyperreflexia, anxiety, and in severe cases, seizures. Conversely, adequate magnesium supports parasympathetic tone and a calm, regulated nervous system baseline.

Form-by-Form Bioavailability: Why the Anion Changes Everything

Magnesium bioavailability is determined primarily by its counter-ion — the molecule it is bound to (the "anion"). Inorganic salts like oxide and carbonate have poor solubility in the GI tract and low absorption. Organic chelates and amino acid complexes dissolve more readily, survive the intestinal environment better, and in some cases carry magnesium across transport mechanisms that bypass ordinary absorption limits.

The key practical takeaway: oxide is the dominant form in cheap "500 mg magnesium" tablets and is largely a laxative. For any therapeutic purpose — sleep, cognition, muscle recovery, or genuine repletion — an organic chelate is required. The choice between chelates depends on your specific goal.

Magnesium L-Threonate & the Brain: The Slutsky 2010 Breakthrough

Magnesium L-threonate (trade name MagTein) was developed specifically to solve a problem that had frustrated neurologists for decades: how do you raise magnesium levels in the brain without flooding the periphery with doses high enough to cause diarrhoea?

The breakthrough came in a landmark 2010 paper published in Neuron by Inna Slutsky and colleagues at MIT. The researchers demonstrated that elevating brain magnesium — specifically using the threonate form — increased synaptic density in the hippocampus, enhanced both short-term and long-term memory in young and aged rats, and reversed age-related cognitive decline. The mechanism involves upregulation of NR2B-containing NMDA receptors and AMPA receptor trafficking — the same synaptic machinery involved in long-term potentiation (LTP), the cellular correlate of memory formation.

MMFS-01 Human Trials

Subsequent human trials using the commercial formulation (branded MMFS-01) demonstrated measurable improvements in cognitive assessments in older adults with mild cognitive impairment. A 2016 randomised controlled trial found that supplementation with 1.5–2 g of magnesium L-threonate daily for 12 weeks significantly improved scores on episodic memory and executive function tests relative to placebo, with the effect size correlating with the degree of baseline cognitive impairment — i.e., those with more to recover showed the largest gains.

Sleep Architecture

An underappreciated secondary benefit of magnesium L-threonate is its effect on sleep quality. By increasing brain magnesium, it enhances GABAergic inhibitory tone and reduces the hyperactive NMDA signalling that contributes to evening cortical excitability — the neurological basis of "wired but tired." Multiple users and clinicians report that 2 g taken 1–2 hours before bed shortens sleep onset and increases perceived deep sleep without causing morning grogginess, likely because it modulates sleep architecture rather than sedating through a pharmacological mechanism.

Glycinate & Malate for the Body: Sleep, Muscle, and Fibromyalgia

Magnesium Glycinate: The Anxiety and Sleep Form

Magnesium glycinate chelates the mineral to glycine, the smallest amino acid and itself an inhibitory neurotransmitter. Glycine activates glycine receptors in the brainstem and spinal cord, contributing to muscle relaxation and reduction of spinal hyperexcitability. It also modulates GABA-A receptor activity, the primary mechanism through which the nervous system shifts from sympathetic dominance into rest-and-digest mode.

A 2012 randomised controlled trial by Abbasi and colleagues (published in the Journal of Research in Medical Sciences) assigned 46 elderly subjects with insomnia to 500 mg elemental magnesium or placebo for 8 weeks. The magnesium group showed significantly reduced insomnia severity, reduced cortisol, improved melatonin levels, and improved sleep efficiency measured by polysomnography. Serum magnesium and renin both increased, confirming the mineralogical and hormonal mechanisms involved.

For anxiety, the GABA-A mechanism is key. Magnesium binds to and positively modulates GABA-A receptor subunits, producing an effect qualitatively similar to — but far milder and physiologically more appropriate than — benzodiazepines. This is why subclinical magnesium deficiency is mechanistically linked to anxiety disorders and why repletion frequently produces a subjective reduction in background tension without pharmacological sedation.

Magnesium Malate: Energy Production and Fibromyalgia

Malate (malic acid) is a direct intermediate of the Krebs cycle — the mitochondrial pathway responsible for generating the majority of cellular ATP. By delivering magnesium complexed with malate, supplementation simultaneously addresses two interdependent variables: magnesium as a cofactor for Krebs cycle enzymes, and malate as a substrate for those same reactions.

This dual action makes magnesium malate particularly relevant to fibromyalgia, a condition characterised in part by impaired mitochondrial energy metabolism and intramuscular ATP depletion. A clinical study by Abraham and Flechas found that patients with fibromyalgia who received magnesium malate (1,200–2,400 mg malate with 300–600 mg magnesium) for 8 weeks reported significant reductions in tender point index and pain scores, with rapid return of symptoms upon withdrawal — a pattern consistent with genuine metabolic dependence rather than placebo.

For athletes and active individuals, magnesium malate before training may reduce muscle soreness and support faster lactate clearance, as malate can accept electrons from NADH and contribute to the malate-aspartate shuttle, reducing oxidative stress during high-intensity exercise.

Deficiency Signs, RDA vs Therapeutic Dose, and the Full Dosing Protocol

Recognising Magnesium Deficiency

Magnesium deficiency exists on a spectrum. Severe deficiency (hypomagnesemia) produces dramatic symptoms and is detectable by blood test. Subclinical insufficiency — far more common and far more often missed — presents as a cluster of non-specific symptoms that most clinicians attribute to stress, poor sleep, or anxiety without testing magnesium status:

• Muscle cramps and twitching — particularly nocturnal leg cramps and eyelid fasciculations
• Sleep disruption — difficulty falling asleep, frequent waking, non-restorative sleep
• Anxiety and restlessness — background tension, irritability, difficulty downregulating
• Headaches and migraines — magnesium is one of the most evidence-backed migraine prophylactic supplements
• Fatigue and low exercise tolerance — especially if disproportionate to sleep and training load
• Palpitations — magnesium maintains cardiac electrical conduction and potassium/sodium balance across cardiac membranes
• Constipation — magnesium relaxes intestinal smooth muscle and draws water into the colon

RDA vs Therapeutic Dosing

The RDA for magnesium is 310–320 mg/day for adult women and 400–420 mg/day for adult men. These figures represent the minimum needed to prevent deficiency, not the amount associated with optimal health outcomes. Therapeutic doses in clinical trials typically range from 350–600 mg elemental magnesium per day, and some protocols for migraine prophylaxis or pre-eclampsia prevention use higher doses under medical supervision.

Because different forms vary in elemental magnesium density (oxide is 60%, glycinate is 14%), always calculate dose based on elemental magnesium content, not the listed compound weight.

Cofactors: B6 and Vitamin D3

Vitamin B6 (pyridoxine) enhances intracellular magnesium uptake and reduces urinary excretion. Magnesium and vitamin D3 have a bidirectional relationship: magnesium activates vitamin D by enabling the hepatic and renal hydroxylation steps that convert inactive D3 to 25(OH)D and 1,25(OH)2D, while vitamin D increases intestinal magnesium absorption. Supplementing vitamin D without ensuring adequate magnesium can paradoxically worsen magnesium status — an important consideration for anyone taking high-dose D3.

Key Evidence: Clinical Studies on Magnesium Supplementation

Complete Magnesium Form Comparison Table

Recommended Magnesium Supplements

Related Protocol Guides